1. Won, Wang-Youn, Park, ByungLae, Choi, Sam-Wook, Shin, Hyoung Doo, Kim, Dai-Jin. 2014. Genetic Association of CHRNB3 and CHRNA6 Gene Polymorphisms with Nicotine Dependence Syndrome Scale in Korean Population. In Psychiatry investigation, 11, 307-12. doi:10.4306/pi.2014.11.3.307. https://pubmed.ncbi.nlm.nih.gov/25110504/
2. Drayson, Lucy E, Triplett, Jason W. 2019. A Chrnb3-Cre BAC transgenic mouse line for manipulation of gene expression in retinal ganglion cells. In Genesis (New York, N.Y. : 2000), 57, e23305. doi:10.1002/dvg.23305. https://pubmed.ncbi.nlm.nih.gov/31087513/
3. Bar-Shira, Anat, Gana-Weisz, Mali, Gan-Or, Ziv, Giladi, Nir, Orr-Urtreger, Avi. 2014. CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking. In Neurobiology of aging, 35, 2179.e1-6. doi:10.1016/j.neurobiolaging.2014.03.014. https://pubmed.ncbi.nlm.nih.gov/24731518/
4. Shi, Jing, Chen, Nan, Wang, Zhiren, Yang, Fude, Luo, Xingguang. 2021. Cholinergic receptor nicotinic beta 3 subunit polymorphisms and smoking in male Chinese patients with schizophrenia. In EC psychology and psychiatry, 10, 11-23. doi:. https://pubmed.ncbi.nlm.nih.gov/34368810/